Zobrazeno 1 - 10
of 80
pro vyhledávání: '"HL Gomez"'
Autor:
A. Di Leo, Aron Goldhirsch, J Bernhard, J Chirgwin, K Ribi, HL Gomez, G. Jerusalem, S Aebi, W Luo, P Neven, Alan S. Coates, Bettina Müller, Meredith M. Regan, Marco Colleoni, P Karlsson, Richard D. Gelber, V. Di Lauro, T Ruhstaller, Rudolf Maibach, E Abdi
Publikováno v:
Cancer Research. 78:P5-18
Background: SOLE efficacy results presented at ASCO 2017 showed that extended intermittent vs continuous letrozole for 5 years did not improve disease-free survival in postmenopausal women who had received 4-6 years of adjuvant endocrine therapy for
Autor:
Turner NC; Royal Marsden Hospital, Institute of Cancer Research, London, UK., Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona, Spain.; Breast Cancer Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Howell SJ; The Christie NHS Foundation Trust, Manchester, UK., Dalenc F; Oncopole Claudius Regaud, Institut Universitaire du Cancer de Toulouse Oncopole, Toulouse, France., Cortés J; Oncology Department, International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona, Spain.; Medica Scientia Innovation Research (MedSIR), Barcelona, Spain.; Universidad Europea de Madrid, Faculty of Biomedical & Health Sciences, Department of Medicine, Madrid, Spain., Gomez HL; Instituto Nacional de Enfermedades Neoplásicas (INEN), Departamento de Oncología Médica, Lima, Peru.; Universidad Ricardo Palma, Lima, Peru., Hu X; Department of Breast Cancer & Urological Medical Oncology, Fudan University Shanghai Cancer Center, Shanghai, China., Jhaveri K; Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Krivorotko P; N.N. Petrov National Medical Research Institute of Oncology, St. Petersburg, Russia., Loibl S; German Breast Group, Forschungs, Germany, Neu-Isenburg Centre for Haematology & Oncology, Bethanien, Frankfurt, Germany., Murillo SM; Institut de Recerca Biomèdica, Barcelona, Spain., Park YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea., Sohn JH; Yonsei University College of Medicine, Yonsei Cancer Center, Seoul, Republic of Korea., Toi M; Kyoto University Hospital, Kyoto, Japan., Tokunaga E; National Hospital Organization Kyushu Cancer Center, Fukuoka, Japan., Yousef S; Emek Medical Center, Afula, Israel., Zhukova L; Loginov Moscow Clinical Scientific Center, Moscow, Russia., Bruin E; Oncology R&D, AstraZeneca, Cambridge, UK., Grinsted L; Oncology R&D, AstraZeneca, Cambridge, UK., Schiavon G; Oncology R&D, AstraZeneca, Cambridge, UK., Foxley A; Oncology R&D, AstraZeneca, Cambridge, UK., Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA.
Publikováno v:
Future oncology (London, England) [Future Oncol] 2024 Sep 16, pp. 1-13. Date of Electronic Publication: 2024 Sep 16.
Autor:
Loibl S; German Breast Group, Neu-Isenburg, Germany.; Centre for Haematology and Oncology Bethanien, Frankfurt, Germany., Jassem J; Department of Oncology and Radiotherapy, Medical University of Gdańsk, Gdańsk, Poland., Sonnenblick A; Institute of Oncology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel.; Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel., Parlier D; Clinical Trials Support Unit, Jules Bordet Institute, Brussels, Belgium., Winer E; Yale Cancer Center, New Haven, CT., Bergh J; Department of Oncology-Pathology, Swedish Breast Cancer Group, Karolinska Institute and Breast Cancer Center, Karolinska University Hospital and Karolinska Comprehensive Cancer Center, Stockholm, Sweden., Gelber RD; Dana-Farber Cancer Institute, Harvard Medical School, Harvard TH Chan School of Public Health and Frontier Science and Technology Research Foundation, Boston, MA., Restuccia E; Hoffmann-La Roche Ltd, Basel, Switzerland., Im YH; Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea., Huang CS; National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan., Dalenc F; Oncopole Claudius Regaud, IUCT, Toulouse, France., Calvo I; Breast Cancer Department, MD Anderson Cancer Center, Madrid, Spain.; GEICAM Spanish Breast Cancer Group, Madrid, Spain., Procter M; Frontier Science Scotland Ltd, Kingussie, United Kingdom., Caballero C; Breast International Group (BIG), Brussels, Belgium., Clark E; Roche Products Limited, Welwyn Garden City, United Kingdom., Raimbault A; Breast International Group (BIG), Brussels, Belgium., McConnell R; Frontier Science Scotland Ltd, Kingussie, United Kingdom., Monturus E; Hoffmann-La Roche Ltd, Basel, Switzerland., de Azambuja E; Institut Jules Bordet and L'Université Libre de Bruxelles (ULB), Brussels, Belgium., Gomez HL; Departamento de Oncología Médica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.; Universidad Ricardo Palma, Lima, Peru., Bliss J; The Institute of Cancer Research, London, United Kingdom., Viale G; IEO, European Institute of Oncology, IRCCS, Milan, Italy., Bines J; Instituto Nacional de Cancer, Rio de Janeiro, Brasil., Piccart M; Institut Jules Bordet and L'Université Libre de Bruxelles (ULB), Brussels, Belgium.
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2024 Sep 11, pp. JCO2302505. Date of Electronic Publication: 2024 Sep 11.
Autor:
Rugo HS; Department of Medicine (Hematology/Oncology), University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, USA. Electronic address: hope.rugo@ucsf.edu., Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, Barcelona; Breast Cancer Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain., Howell SJ; Breast Oncology, Division of Cancer Sciences, The University of Manchester, Manchester; The Christie NHS Foundation Trust, Manchester, UK., Dalenc F; Institut Claudius Regaud, Institut Universitaire du Cancer-Oncopole, Toulouse, France., Cortes J; Oncology Department, International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Barcelona; Medica Scientia Innovation Research (MedSIR), Barcelona; Department of Medicine, Universidad Europea de Madrid, Faculty of Biomedical and Health Sciences, Madrid, Spain., Gomez HL; Department of Medical Oncology, Instituto Nacional de Enfermedades Neoplásicas (INEN), Lima; Institute of Investigations in Biomedical Sciences, Universidad Ricardo Palma, Lima, Peru., Hu X; Shanghai Cancer Center, Fudan University, Shanghai, China., Jhaveri KL; Memorial Sloan Kettering Cancer Center, New York; Weill Cornell Medical College, New York, USA., Krivorotko P; Petrov Research Institute of Oncology, Saint Petersburg, Russia., Loibl S; GBG Forschungs GmbH, Neu-Isenburg; Centre for Haematology and Oncology, Bethanien, Frankfurt, Germany., Morales Murillo S; Institut de Recerca Biomèdica, Barcelona, Spain., Nowecki Z; The Maria Skłodowska-Curie Memorial Cancer Center and Institute of Oncology, Warsaw, Poland., Okera M; ICON Cancer Centre, Adelaide, Australia., Park YH; Sungkyunkwan University School of Medicine, Samsung Medical Centre, Seoul., Sohn J; Yonsei University College of Medicine-Yonsei Cancer Center, Seoul, Republic of Korea., Toi M; Kyoto University Hospital, Kyoto., Iwata H; Aichi Cancer Center Hospital, Nagoya, Japan., Yousef S; Emek Medical Center, Afula, Israel., Zhukova L; Loginov Moscow Clinical Scientific Center, Moscow, Russia., Logan J; Oncology R&D, AstraZeneca, Cambridge, UK., Twomey K; Oncology R&D, AstraZeneca, Cambridge, UK., Khatun M; Oncology R&D, AstraZeneca, Cambridge, UK., D'Cruz CM; Oncology R&D, AstraZeneca, Waltham, USA., Turner NC; Royal Marsden Hospital, Institute of Cancer Research, London, UK.
Publikováno v:
ESMO open [ESMO Open] 2024 Sep 05; Vol. 9 (9), pp. 103697. Date of Electronic Publication: 2024 Sep 05.
Autor:
Oliveira M; Medical Oncology Department, Vall d'Hebron University Hospital, and Breast Cancer Unit, Vall d'Hebron Institute of Oncology (VHIO), Barcelona, Spain. Electronic address: moliveira@vhio.net., Rugo HS; University of California San Francisco Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, USA., Howell SJ; The Christie NHS Foundation Trust, Manchester, UK., Dalenc F; Oncopole Claudius Regaud, Institut Universitaire du Cancer-Toulouse, Toulouse, France., Cortes J; Oncology Department, International Breast Cancer Center (IBCC), Pangaea Oncology, Quiron Group, Medica Scientia Innovation Research (MedSIR), Barcelona, Spain; Department of Medicine, Faculty of Biomedical and Health Sciences, Universidad Europea de Madrid, Madrid, Spain., Gomez HL; Departamento de Oncología Médica, Instituto Nacional de Enfermedades Neoplásicas (INEN) and Universidad Ricardo Palma, Lima, Peru., Hu X; Shanghai Cancer Center, Fudan University, Shanghai, China., Toi M; Kyoto University Hospital, Kyoto, Japan., Jhaveri K; Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA., Krivorotko P; Petrov Research Institute of Oncology, St Petersburg, Russia., Loibl S; GBG Forschungs GmbH, Neu-Isenburg and Centre for Haematology and Oncology, Frankfurt, Germany., Morales Murillo S; Institut de Recerca Biomèdica, Barcelona, Spain., Okera M; Icon Cancer Centre, Adelaide, SA, Australia., Nowecki Z; Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland., Park YH; Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul, South Korea., Sohn JH; Yonsei University College of Medicine, Yonsei Cancer Center, Seoul, South Korea., Tokunaga E; NHO Kyushu Cancer Center, Fukuoka, Japan., Yousef S; Emek Medical Center, Afula, Israel., Zhukova L; Loginov Moscow Clinical Scientific Center, Moscow, Russia., Fulford M; Oncology R&D, AstraZeneca, Warsaw, Poland., Andrews H; Oncology R&D, AstraZeneca, Gaithersburg, MD, USA., Wadsworth I; Oncology R&D, AstraZeneca, Cambridge, UK; PHASTAR, London, UK., D'Cruz C; Oncology R&D, AstraZeneca, Waltham, MA, USA., Turner NC; Royal Marsden Hospital, Institute of Cancer Research, London, UK.
Publikováno v:
The Lancet. Oncology [Lancet Oncol] 2024 Sep; Vol. 25 (9), pp. 1231-1244.
Autor:
Hyams DM; Medical Director, Desert Surgical Oncology, Eisenhower Medical Center, Rancho Mirage, California, USA., Bareket-Samish A; BioInsight Ltd., Binyamina, Israel., Rocha JEB; Breast Cancer Department, Instituto Nacional de Cancerología Mexico and Centro Medico ABC, Mexico City, Mexico., Diaz-Botero S; Breast Surgical Oncology Unit, Cancer Center at Clínica Universidad de Navarra, Madrid, Spain., Franco S; Medical Director, Centro de Tratamiento e Investigación sobre el Cáncer, CTIC, Bogotá, Colombia., Gagliato D; Department of Clinical Oncology, Beneficencia Portuguesa de Sao Paulo, San Paulo, Brazil., Gomez HL; Breast Unit Director, OncoSalud, Clinica Delgado, AUNA, Universidad Ricardo Palma, Universidad Peruana Cayetano Heredia, Lima, Peru., Korbenfeld E; Department of Oncology, Hospital Británico de Buenos Aires, Buenos Aires, Argentina., Krygier G; Department of Oncology, Universitary Hospital de Clínicas, Montevideo, Uruguay., Mattar A; Director of Mastology Center, Centro de Referência da Saúde da Mulher, Hospital da Mulher, São Paulo, Brazil., De Pierro AN; Department of Surgery, Unit of Mastology, Hospital J.A. Fernandez, Buenos Aires City, Argentina., Borrego MR; Medical Oncology Service, Hospital Universitario Virgen del Rocío, Seville, Spain., Villarreal C; Head, Department of Medical Oncology, Breast Cancer Center, Hospital Zambrano Hellion TecSalud, Tecnologico de Monterrey, Monterrey, Nuevo Leon, Mexico.
Publikováno v:
Journal of surgical oncology [J Surg Oncol] 2024 Aug; Vol. 130 (2), pp. 166-187. Date of Electronic Publication: 2024 Jun 24.
Autor:
Otoya I; Department of Medical Oncology Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Valdiviezo N; Department of Medical Oncology Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Morante Z; Department of Medical Oncology Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Calle C; Department of Medical Oncology Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Ferreyra Y; Department of Bioengineering Universidad de Ingeniería y Tecnología, Lima, Peru., Huarcaya-Chombo N; Faculty of Science and Engineering Universidad Peruana Cayetano Heredia, Lima, Peru., Polo-Mendoza G; Department of Bioengineering Universidad de Ingeniería y Tecnología, Lima, Peru., Castañeda C; Department of Medical Oncology Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Vidaurre T; Department of Medical Oncology Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Neciosup SP; Department of Medical Oncology Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Calderón MJ; Department of Medical Oncology Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.; Institute of Investigations in Biomedical Sciences (INICIB) Universidad Ricardo Palma, Lima, Peru., Gomez HL; Department of Medical Oncology Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.; Institute of Investigations in Biomedical Sciences (INICIB) Universidad Ricardo Palma, Lima, Peru.; Oncosalud Auna Ideas, Lima, Peru.
Publikováno v:
International journal of breast cancer [Int J Breast Cancer] 2024 Jun 22; Vol. 2024, pp. 9551710. Date of Electronic Publication: 2024 Jun 22 (Print Publication: 2024).
Autor:
Otoya I; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Perú.; https://orcid.org/0000-0001-6185-9853., Valdiviezo N; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Perú.; https://orcid.org/0000-0002-4300-5958., Roque K; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Perú.; Post Graduation Programme in Medicine, UNINOVE, Sao Paulo 03155-000, Brasil.; https://orcid.org/0000-0003-3267-7107., Morante Z; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Perú.; https://orcid.org/0000-0003-2952-6068., Vidaurre T; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Perú.; https://orcid.org/0000-0003-1995-4560., Neciosup SP; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Perú.; https://orcid.org/0000-0002-2657-9853., Calderón MJ; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Perú.; Institute of Investigations in Biomedical Sciences (INICIB), Universidad Ricardo Palma, Lima 15039, Perú.; https://orcid.org/0000-0003-4935-7927., Gomez HL; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima 15038, Perú.; Institute of Investigations in Biomedical Sciences (INICIB), Universidad Ricardo Palma, Lima 15039, Perú.; Oncosalud, Auna Ideas, Lima 15036, Perú.; https://orcid.org/0000-0003-2660-1843.
Publikováno v:
Ecancermedicalscience [Ecancermedicalscience] 2024 May 31; Vol. 18, pp. 1708. Date of Electronic Publication: 2024 May 31 (Print Publication: 2024).
Autor:
Al Sukhun S; Al Hyatt Oncology Practice, Amman, Jordan., Temin S; American Society of Clinical Oncology, Alexandria, VA., Barrios CH; Oncoclinicas Group, Porto Alegre, Brazil., Antone NZ; Institutul Oncologic Prof Dr Ion Chiricuta, Cluj-Napoca, Romania., Guerra YC; Departamento de Hemato-Oncología, Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico., Chavez-MacGregor M; University of Texas MD Anderson Cancer Center, Houston, TX., Chopra R; Gurugram, India., Danso MA; Virginia Oncology Associates, Norfolk, VA., Gomez HL; Institute Nac de Enfermedades Neoplas, Surquillo, Peru., Homian NM; CHU Treichville, Abidjan, Cote d'Ivoire., Kandil A; Alexandria Comprehensive Cancer Center, Alexandria, Egypt., Kithaka B; Kilele Health Association, Nairobi, Kenya., Koczwara B; Flinders Medical Centre, Bedford Park, Australia., Moy B; Massachusetts General Hospital, Boston, MA., Nakigudde G; Uganda Women's Cancer Support Organisation, Kampala, Uganda., Petracci FE; Instituto Alexander Fleming, Buenos Aires, Argentina., Rugo HS; University of California San Francisco, San Francisco, CA., El Saghir NS; American University of Beirut, Beirut, Lebanon., Arun BK; University of Texas MD Anderson Cancer Center, Houston, TX.
Publikováno v:
JCO global oncology [JCO Glob Oncol] 2024 Jan; Vol. 10, pp. e2300285.
Autor:
Morante Z; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru.; Oncosalud, AUNA, Lima, Peru., Ferreyra Y; Departamento de Bioingeniería, Universidad de Ingeniería y Tecnología, Lima, Peru., Pinto JA; Centro de Investigación Básica y traslacional, Auna Ideas, Lima, Peru., Valdivieso N; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Castañeda C; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Vidaurre T; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Valencia G; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Rioja P; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Fuentes H; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Cotrina JM; Departamento de Cirugía en Mamas y Tejidos Blandos, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Neciosup S; Departamento de Medicina Oncológica, Instituto Nacional de Enfermedades Neoplásicas, Lima, Peru., Gomez HL; Oncosalud, AUNA, Lima, Peru.; Instituto de Investigaciones en Ciencias Biomédicas (INICIB), Universidad Ricardo Palma, Lima, Peru.
Publikováno v:
Frontiers in oncology [Front Oncol] 2023 Nov 06; Vol. 13, pp. 1193927. Date of Electronic Publication: 2023 Nov 06 (Print Publication: 2023).